Clinical Trial Update: Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effects of reducing enzalutamide dose on fatigue, cognition, and drug trough levels in men with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Macquarie University, Australia | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN